Schizophrenia Blog

Whether or not marijuana is causal in the development of schizophrenia, it seems that there is now a possibility that it may be able to atone for its sins. One of the components of marijuana, cannabidiol, has been found in a recent study to treat the symptoms of schizophrenia as effectively as antipsychotic but with few side effects.

We are constantly looking for new treatments for schizophrenia and it is our ambition to bring them all to you here in one place and to follow up on their progress. One recent potential treatment that has obtained some press involves stem cells.

Finding a medication that works to treat an individual with schizophrenia can be a difficult job for a psychiatrist. Their job is complicated because schizophrenia is not a single ailment and is still not well understood. The treatment of it by traditional medication often involves a hit and miss approach with different medications and often cocktails of antipsychotics, antidepressants and antianxiety tablets. So what hope is there of finding a supplement that can treat the symptoms of Schizophrenia? The answer lies in what we regard as "treatment for schizophrenia". In the case of SBX our initial ambition was to produce a supplement that "helped" the sufferers of schizophrenia. It was later that we realized that what this meant is that it needed to contain ingredients that studies had shown (or at least strongly suggested) could do at least one of the following things

The amount of evidence suggesting that certain vitamins, herbs and nutrients may be a helpful part of any schizophrenia treatment, grows month by month. Given this it is surprising to me that SBX remains the only manufacturer of a supplement specifically designed to help treat schizophrenia.

Researchers continue to find evidence that the ingredients in SBX work to reduce the symptoms of schizophrenia. This time it is Vitamin B12 and Folate (also known as vitamin B9). SBX has contained both of these vitamins since it was first developed. In the article below we will look at the recent study on the B Vitamins ability to fight schizophrenia.

SBX was born of a desire to understand if there were steps that could be taken, in addition to taking antipsychotics, that may reduce symptoms of schizophrenia, or even help lead to a recovery from schizophrenia. This Blog is about why we believe the ingredients in SBX work to reduce the symptoms of schizophrenia. Please keep in mind though that SBX is not just about vitamins and supplements. A holistic approach to health is required and this is even more so when trying to recover from schizophrenia.

An Amino Acid drink, Tyrodep, was developed in 2004 by professor Guy Goodwin as a possible complementary treatment for schizophrenia. Initial studies showed that it may be able to help moderate chemical levels in the brain that cause some of the symptoms of schizophrenia.

Typical antipsychotics have side affects that are well known to those that take them and their doctors. That is the reason we developed SBX in the hope that dosages might be able to be reduced. But what if a simple heartburn medication could be taken (albeit in a 5x higher dose) and improve the symptoms of someone suffering from schizophrenia?

Researchers of schizophrenia at King's College London Institute of Psychiatry (UCL) and the Wellcome Trust have developed a surprising new therapy as a treatment for schizophrenia. In a futuristic and "science fiction" like approach they have developed an avatar system that aids sufferers of schizophrenia by reducing positive symptoms (i.e., auditory hallucinations).

It is commonly known that: major mental health disorders such as schizophrenia, run in the family; that around 1% of the population in the U.S. suffer from schizophrenia, and that 10% of people in the U.S. who have a first-degree relative with the disorder, such as a parent, brother, or sister suffer from schizophrenia. People who have second-degree relatives (aunts, uncles, grandparents, or cousins) with the disease also develop schizophrenia more often than the general population. The risk is highest for an identical twin of a person with schizophrenia. He or she has a 40% to 65% of developing the disorder (See Harrison PJ and Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry. 2005;10(1):40-68.)